AU2003209534A1 - The method of treating tuberculosis - Google Patents

The method of treating tuberculosis

Info

Publication number
AU2003209534A1
AU2003209534A1 AU2003209534A AU2003209534A AU2003209534A1 AU 2003209534 A1 AU2003209534 A1 AU 2003209534A1 AU 2003209534 A AU2003209534 A AU 2003209534A AU 2003209534 A AU2003209534 A AU 2003209534A AU 2003209534 A1 AU2003209534 A1 AU 2003209534A1
Authority
AU
Australia
Prior art keywords
treating tuberculosis
tuberculosis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003209534A
Other versions
AU2003209534A8 (en
Inventor
Bakulesh Mafatlal Khamar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003209534A1 publication Critical patent/AU2003209534A1/en
Publication of AU2003209534A8 publication Critical patent/AU2003209534A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003209534A 2002-03-08 2003-03-04 The method of treating tuberculosis Abandoned AU2003209534A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN235/MUM/2002 2002-03-08
IN235MU2002 2002-03-08
PCT/IB2003/000802 WO2003075825A2 (en) 2002-03-08 2003-03-04 The method of treating tuberculosis

Publications (2)

Publication Number Publication Date
AU2003209534A1 true AU2003209534A1 (en) 2003-09-22
AU2003209534A8 AU2003209534A8 (en) 2003-09-22

Family

ID=27799867

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2003209534A Abandoned AU2003209534A1 (en) 2002-03-08 2003-03-04 The method of treating tuberculosis
AU2003208505A Abandoned AU2003208505A1 (en) 2002-03-08 2003-03-06 Process for preparation of a pharmaceutical composition containing acid labile compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2003208505A Abandoned AU2003208505A1 (en) 2002-03-08 2003-03-06 Process for preparation of a pharmaceutical composition containing acid labile compounds

Country Status (4)

Country Link
KR (1) KR20050008452A (en)
AU (2) AU2003209534A1 (en)
GB (1) GB2392839A (en)
WO (2) WO2003075825A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006111853A2 (en) * 2005-04-18 2006-10-26 Aurobindo Pharma Limited Stable solid dosage forms of acid labile drug
AU2006238906B2 (en) 2005-04-25 2013-04-11 Cadila Pharmaceuticals Ltd. Vaccine adjuvants
EP2359837A1 (en) * 2006-11-23 2011-08-24 Cadila Pharmaceuticals Ltd. Poly-tlr antagonist
WO2010122583A2 (en) 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8918206D0 (en) * 1989-08-09 1989-09-20 Nat Inst Immunology Tuberculosis vaccine
US5232706A (en) * 1990-12-31 1993-08-03 Esteve Quimica, S.A. Oral pharmaceutical preparation containing omeprazol
SE9302395D0 (en) * 1993-07-09 1993-07-09 Ab Astra NEW PHARMACEUTICAL FORMULATION
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
EP1478391A1 (en) * 2002-01-29 2004-11-24 Bakulesh Mafatlal Khamar Method of providing prophylaxis for tuberculosis in hiv positive individuals

Also Published As

Publication number Publication date
AU2003208505A8 (en) 2003-09-29
WO2003075825A3 (en) 2003-11-13
WO2003077829A3 (en) 2003-12-04
GB0400094D0 (en) 2004-02-04
KR20050008452A (en) 2005-01-21
WO2003075825A2 (en) 2003-09-18
AU2003208505A1 (en) 2003-09-29
WO2003077829A2 (en) 2003-09-25
AU2003209534A8 (en) 2003-09-22
GB2392839A8 (en) 2004-11-18
GB2392839A (en) 2004-03-17

Similar Documents

Publication Publication Date Title
HK1249850A1 (en) Method for the treatment of multiple sclerosis
AU2003297762A1 (en) Methods for treating essential tremor
AU2003280004A1 (en) Hair treatment method
AU2003260959A1 (en) Light-emitting apparatus and fabrication method of the same
AU2003247624A1 (en) Method of treating the syndrome of lipodystrophy
AU2003226094A1 (en) Compounds and methods
AU2003283958A1 (en) Method of treating tremors
AU2003277596A1 (en) Method of deuterization
AU2002359950A1 (en) Plasma treatment method
AU2003258551A1 (en) Method for the treatment of fiber material
AUPS160602A0 (en) Therapeutic method
AU2002338191A1 (en) Surface treatment system and surface treatment method
AU2003258070A1 (en) Electrodionization method
AU2003233820A1 (en) Method for the treatment of starch
AU2003227987A1 (en) Machining apparatus and methods
AU2002359074A1 (en) Surface treatment system and method
AU2002359061A1 (en) Surface treatment system and method thereof
AU2003209534A1 (en) The method of treating tuberculosis
AU2002951913A0 (en) Method of treatment
AU2003237199A1 (en) Method of treating multiple sclerosis
AU2003236232A1 (en) Method for treatment of textile
AU2003213109A1 (en) Method for treating cellulite
AU2003278535A1 (en) Histoscreen method
AU2003255785A1 (en) Method of authentication
AU2003206325A1 (en) Coating method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase